Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis

Rheumatology (United Kingdom)

Volumn 53, Issue 1, 2014, Pages 104-113

  Ciccia, Francesco ^a   Alessandro, Riccardo ^a   Rizzo, Aroldo ^b   Accardo Palumbo, Antonina ^b   Raimondo, Stefania ^a   Raiata, Francesca ^b   Guggino, Giuliana ^a   Giardina, AnnaRita ^a   De Leo, Giacomo ^a   Sireci, Guido ^a   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello   (Italy)

Author keywords

Ankylosing spondylitis; Gut inflammation; Interleukin 33; M1 macrophages; M2 macrophages; Resolution phase macrophages

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; GAMMA INTERFERON; HLA B27 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; STAT6 PROTEIN;

ADAPTIVE IMMUNITY; ANKYLOSING SPONDYLITIS; ARTICLE; CELL EXPANSION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENTERITIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANKYLOSING SPONDYLITIS; GUT INFLAMMATION; INTERLEUKIN 33; M1 MACROPHAGES; M2 MACROPHAGES; RESOLUTION PHASE MACROPHAGES;

ADULT; AGED; BIOPSY; CYTOKINES; DNA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; ILEITIS; ILEUM; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84890911327     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket323     Document Type: Article

References (34)

1. De Vos M, Cuvelier C, Mielants H et al. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96(2 Pt 1):339-44.
2. De Vos M, Mielants H, Cuvelier C et al. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703.
3. Mielants H, Veys EM, Cuvelier C et al. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27(Suppl. 2):95-105.
4. Demetter P, Baeten D, De Keyser F et al. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex. Ann Rheum Dis 2000;59:211-6.
5. Van Damme N, Elewaut D, Baeten D et al. Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with aEb7 integrin. Clin Exp Rheumatol 2001;19:681-7.
6. Demetter P, Van Huysse JA, De Keyser F et al. Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis. J Pathol 2002;198:517-22.
7. Demetter P, De Vos M, Van Huysse JA et al. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. Ann Rheum Dis 2005;64:321-4.
8. Ciccia F, Bombardieri M, Principato A et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009;60:955-65.
9. Ciccia F, Accardo-Palumbo A, Alessandro R et al. Interleukin-22 and IL-22-producing NKp44(+) NK cells in the subclinical gut inflammation of patients with ankylosing spondylitis. Arthritis Rheum 2012;64:1869-78.
10. Ciccia F, Accardo-Palumbo A, Giardina A et al. Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response. Arthritis Rheum 2010;62:3625-34.
11. Smith PD, Smythies LE, Shen R et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol 2011;4:31-42.
12. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787-95.
13. Mantovani A, Biswas SK, Galdiero MR et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013;229:176-85.
14. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32:593-604.
15. Bystrom J, Evans I, Newson J et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008;112:4117-27.
16. Ueda Y, Kayama H, Jeon SG et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int Immunol 2010;22:953-62.
17. Smith PD, Smythies LE, Mosteller-Barnum M et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001;167:2651-6.
18. Grimm MC, Pavli P, Van de Pol E et al. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin Exp Immunol 1995;100:291-7.
19. Kamada N, Hisamatsu T, Honda H et al. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J Immunol 2009;183:1724-31.
20. Kamada N, Hisamatsu T, Okamoto S et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 2008;118:2269-80.
21. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
22. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
23. Best WR, Becktel JM, Singleton JW et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
24. Kurowska-Stolarska M, Stolarski B, Kewin P et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009;183:6469-77.
25. Vandooren B, Noordenbos T, Ambarus C et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009;60:966-75.
26. Pandey AK, Yang Y, Jiang Z et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 2009;5: e1000500.
27. Liew FY. IL-33: a Janus cytokine. Ann Rheum Dis 2012;71(Suppl. 2):i101-4.
28. Ciccia F, Alessandro R, Rizzo A et al. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis 2013;72:258-64.
29. Terras S, Opitz E, Moritz RK et al. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis 2013;72:144-5.
30. Sponheim J, Pollheimer J, Olsen T et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol 2010;177:2804-15.
31. Han GW, Zeng LW, Liang CX et al. Serum levels of IL-33 is increased in patients with ankylosing spondylitis. Clin Rheumatol 2011;30:1583-8.
32. Baumann CL, Aspalter IM, Sharif O et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 2010;207:2689-701.
33. Melgar S, Yeung MM, Bas A et al. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 2003;134:127-37.
34. Jungi TW, Brcic M, Eperon S et al. Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages. Thromb Res 1994;76:463-74.